Notice of Change to PAR-23-021, "Avenir Award Program for Genetic or Epigenetic of Substance Use Disorders (DP1 Clinical Trial Optional)" | 11 Academia Networks
Salta al contenuto principale
Publish
Home
The Power of Niche Career Hubs
  • Publish
  • Accedi
  • Create Account
The Power of Niche Career Hubs
LinkedIn
Facebook
BlueSky
Reddit
X
Share Options
Share Options
Whatsapp
Threads
Email
LinkedIn
Facebook
BlueSky
Reddit
X
Whatsapp
Threads
Email

Notice of Change to PAR-23-021, "Avenir Award Program for Genetic or Epigenetic of Substance Use Disorders (DP1 Clinical Trial Optional)"

National Institutes of Health
Tipo

Research/project funding

Posted on

15 May 2025

Notice NOT-DA-24-062 from the NIH Guide for Grants and Contracts

More Information

Visit Website

Tipo

Research/Project Funding

Posted on

15 May 2025

Turn On Deadline Reminders

, Stati Uniti

  • not-da-24-062
  • genetic
  • nih guide
  • epigenetic
  • avenir award program
  • scholarship
  • national institutes of health
  • contracts notice

    Also Interesting

    • Research/Project Funding Opportunity

    Notice of Early Expiration of PAR-24-055 "Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)"

    • Research/Project Funding Opportunity

    Notice of Change: Expiration of RFA-NS-24-019: HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

    • Research/Project Funding Opportunity

    Notice of Change to Key Dates Listed in PAR-22-130, "NIA Program Project Applications (P01 Clinical Trial Optional)"

Links

Footer menu

  • Our Story
  • Advertise
  • Careers
  • Contact
  • Aiuto
  • Partners
  • Referenze
  • Termini e le Condizioni

Customer Support

+49 (0)30 - 2084712 50
info@11academianetworks.com

Language

Copyright © 2016-2025 11 Academia Networks. All rights reserved

×

Login to your account

Indirizzo email

Password

Forgot your password? Click here.

Google
Login with Google
or